NCT07649083Not yet recruiting
Comparison of Tunneled Cuffed Dialysis Catheters Versus Arteriovenous Fistulae in Elderly or Multimorbid Patients
Source: ClinicalTrials.gov · Last updated 16 Jun 2026
Brief summary (registry, in English)
Patients are randomly assigned to a study group. Depending on the study group, either an arteriovenous fistula or tunneled cuffed catheter (TCC) will be implanted, followed by continuous evaluation of the patients during the first year after initiating the vascular access. The evaluation includes statistical evaluation of all events, including loss of access, thrombosis, infection, loss of patency, increase in co-morbidities, e.g. congestive heart failure as well as quality of life. The implantation of the TCC is a standard procedure and it will be used only in accordance with the approved instructions of use on subjects who have signed an informed consent form. The surgery is a standard operation and it will be performed by specialized surgeons on subjects who have signed an informed consent form (No grafts will be used; implantation of a standard TCC, used at the Department of Nephrology). Both, an arteriovenous fistula or a TCC, will be used for routine chronic haemodialysis
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 220 (estimated)
- First submitted
- 11 Jun 2026
- Start date
- 1 Aug 2026
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- Medical University of Vienna
- Diseases
- Chronic kidney disease
- NCT number
- NCT07649083
What you commit to
- Study type: Interventional
- Planned participants: 220
- From 1 Aug 2026 to the primary completion date, 31 Dec 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Major surgery within 12 weeks before screening
Other illness
- Poor overall health or malignancy not in remission at screening
- Endovascular arteriovenous fistula
Lab values
- Uncontrolled infection and/or CRP \>5 mg/dl (normal \<0.5 mg/dl) at screening
Other
- Pre-existent vascular access
- Patient not eligible for any one of the vascular access options
Who the study is looking for
- Aged ≥60 years or \<60 years with a CCI Score \>6
- Patients with CKD G5 A1-3 with indication for hemodialysis
- Stable clinical condition
- Eligibility for both arteriovenous fistula on the upper extremities and TCC
- Availability for follow-up
- Written informed consent
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.